会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • Method for determining an active agent dose
    • 确定活性剂剂量的方法
    • US20050074803A1
    • 2005-04-07
    • US10947982
    • 2004-09-23
    • Walter SchmittStefan WillmannEdgar DiesselIngmar DornJens Burmeister
    • Walter SchmittStefan WillmannEdgar DiesselIngmar DornJens Burmeister
    • G06F19/18G06Q50/24C12Q1/68G06F17/60G06F19/00G01N33/48G01N33/50
    • G06Q50/24G16B20/00
    • Method for determining the dose of at least one active agent based on a genetic analysis. The method comprises analyzing specific genes for their nucleotide sequence or their expression levels of gene-specific proteins and/or RNA molecules. The gene-specific data is assigned one or more relevant physiological functions of the human or animal body, in particular those which have an influence on the metabolism, absorption, excretion or distribution of the active agent in the body. The gene-specific data and the assigned physiological functions are then integrated into a physiology-based pharmacokinetic model (PBPK model). The PBPK model integrates pharmacokinetic data relating to one or more active agents. The PBPK model may also receive and evaluate patient-specific data directly inputted and combined with data from a knowledge database comprising known values of pharmacokinetic parameters. The PBPK's integration of these data provide a calculation of the individual dose of the active agent.
    • 基于遗传分析确定至少一种活性剂的剂量的方法。 该方法包括分析其核苷酸序列的特定基因或其基因特异性蛋白质和/或RNA分子的表达水平。 基因特异性数据被分配人或动物体的一个或多个相关的生理功能,特别是那些对体内活性剂的代谢,吸收,排泄或分布有影响的那些。 然后将基因特异性数据和分配的生理功能整合到基于生理学的药代动力学模型(PBPK模型)中。 PBPK模型整合了与一种或多种活性剂有关的药代动力学数据。 PBPK模型还可以接收和评估直接输入的患者特异性数据,并与包括已知的药代动力学参数值的知识数据库的数据组合。 PBPK对这些数据的整合提供了活性剂个体剂量的计算。